Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

5.72
Delayed Data
As of May 24
 +0.16 / +2.88%
Today’s Change
5.35
Today|||52-Week Range
19.43
-57.85%
Year-to-Date
No recent news for ImmunoGen Inc.

Today’s Trading

Previous close5.56
Today’s open5.64
Day’s range5.62 - 5.86
Volume2,852,616
Average volume (3 months)1,228,830
Market cap$484.1M
Dividend yield--
Data as of 3:59pm ET, 05/24/2016

Growth & Valuation

Earnings growth (last year)+14.46%
Earnings growth (this year)-116.20%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+42.82%
P/E ratioNM
Price/Sales14.46
Price/Book13.71

Competitors

 Today’s
change
Today’s
% change
BPMCBlueprint Medicines ...+0.32+1.79%
CYADCelyad SA+1.39+2.79%
ATRAAtara Biotherapeutic...+0.43+2.45%
XBITXBiotech Inc+0.55+4.09%
Data as of 3:59pm ET, 05/24/2016

Financials

Next reporting dateJuly 29, 2016
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$85.5M
Annual profit (last year)-$60.7M
Net profit margin-71.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers

Search for Jobs